Histamine Intolerance

Histamine Intolerance (HIT) is a metabolic capacity problem. It occurs when Histamine intake and production exceed the body’s ability to break it down. The Mast Cells themselves may be functioning normally — the problem is in the plumbing, not the faucet.

The Core Mechanism

In HIT, the equation is simple:

Histamine in > Histamine cleared = Symptoms

Sources of histamine in:

Clearance mechanisms:

  • DAO — extracellular, primarily gut
  • HNMT — intracellular, primarily brain and liver

HIT occurs when one or both enzymes can’t keep up. This can be genetic (variant enzymes with reduced function), acquired (gut damage reducing DAO production, medications inhibiting DAO), or both.

How It Differs from MCAS

This distinction matters because it changes what’s happening upstream and therefore what interventions make sense.

HITMCAS
The problemEnzyme capacity too lowMast cells too reactive
Mast cell behaviorNormalAbnormal — firing too easily, too often
Primary source of excess histamineExogenous (diet) + bacterialEndogenous (mast cell overproduction)
Response to low-histamine dietOften significant improvementPartial improvement (reduces one input but doesn’t address the source)
DAO supplementationCan be helpful (adds clearance)May help with dietary component, but doesn’t address mast cell overactivation
Mast cell stabilizersLess relevant (mast cells aren’t the primary problem)Core intervention
TryptaseNormalMay be elevated (but often normal in piecemeal Degranulation)

See HIT vs MCAS for the full comparison, including how they compound each other.

Symptoms

The symptoms are identical to mild-moderate MCAS because the downstream mediator is the same — Histamine. Common presentations include:

  • Flushing, especially after meals
  • Headaches or migraines
  • Nasal congestion, sneezing, runny nose
  • GI symptoms: bloating, diarrhea, abdominal cramps, nausea
  • Urticaria (hives), itching
  • Anxiety-like symptoms (histamine activates the sympathetic nervous system)
  • Tachycardia
  • Menstrual cycle variation (see Estrogen and Mast Cells — estrogen affects DAO activity)

Symptoms typically correlate with meals, especially meals high in Dietary Histamine, and may worsen with alcohol (which inhibits DAO and delivers histamine).

Diagnosis

There is no single definitive test. Diagnosis is typically based on:

  • Clinical history: Symptom correlation with high-histamine foods and DAO inhibitors
  • DAO Serum Levels: Low serum DAO supports the diagnosis but has limitations
  • Response to intervention: Improvement on a low-histamine diet + DAO supplementation is often used as a diagnostic confirmation
  • Genetic testing: AOC1 variants can confirm reduced genetic DAO capacity but don’t diagnose HIT alone (see DAO)

The overlap problem

Someone can have BOTH HIT and MCAS simultaneously. Reduced enzyme capacity (HIT) + overactive mast cells (MCAS) = the worst of both worlds. The enzyme system can’t keep up even with normal mast cell output, AND the mast cells are producing more than normal. Teasing these apart requires looking at the full picture — see HIT vs MCAS.

Prevalence

Estimates suggest 1-3% of the population has clinically significant histamine intolerance. It’s more common in women, possibly because estrogen affects both mast cell activity and DAO expression. It’s likely underdiagnosed because the symptoms overlap with many other conditions (IBS, anxiety, migraines).